BSX vs PCG · P/E 20, rev $16.75B vs P/E 13, $37.68B cap
Boston Scientific Corp (BSX) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
PCG does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the BSX and PCG stock pages for the full models.
Not investment advice.